GSK enters agreement to acquire IDRx for $1.15 Billion to strengthen cancer portfolio
UK pharmaceutical giant GSK has confirmed that it has signed an agreement to acquire the privately-held biotechnology company IDRx.
Tag: GSK
Pharmaceutical companies can no longer cope with forex scarcity as multinationals withdraw- PMG-MAN
The Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria (PMG-MAN) expressed serious concerns over the scarcity of foreign exchange ...
NGX delists GlaxoSmithKline Consumer Nigeria Plc from daily official list
The Nigerian Exchange Limited (NGX) has delisted the Shares of GlaxoSmithKline Consumer Nigeria (GSK) Plc from its Daily Official List ...
NGX suspends trading on the shares of GSK for delisting
The Nigerian Exchange Limited (NGX) has suspended trading on the shares of Glaxo SmithKline Consumer Nigeria (GSK) Plc for eventual ...
GSK gets SEC approval for scheme of arrangement to delist from NGX
The Board of GlaxoSmithKline Consumer Nigeria Plc (GSK) has announced that the Company has received the Securities and Exchange Commission’s ...
LSHTM, GSK offers scholarships to Africans for a Masters in public health in London
LSHTM and GSK are offering scholarships to support the training and development of the next generation of leaders in global ...
Court ordered meeting: Shareholders approves delisting of GSK from NGX, to receive N17.42 per share
Shareholders of GSK Consumer Nigeria Plc have approved the payment of N17.42 for every share held by its shareholders.
Drug imports in Nigeria rise by 68% by Q3 2023 over weak naira, GSK exit
Medications worth N81.81 billion were imported into Nigeria from July to September 2023.
Cameroon becomes first African Recipient of malaria vaccine as Nigeria anticipates turn
Cameroon achieved a milestone in the battle against malaria as it welcomed the initial shipment of Mosquirix malaria vaccines from ...
Drug prices soar as high as 1000% over GSK exit from Nigeria
Following the recent announcement of GlaxoSmithKline's (GSK) departure from the Nigerian pharmaceutical market, there has been a notable surge in ...
